Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Am J Ther. 2011 Sep;18(5):e153-6. doi: 10.1097/MJT.0b013e3182258e2e.
Triptans have been used for the acute treatment of migraine headaches for many years. Although their use can lead to coronary vasospasm, there are very few reports of triptans actually leading to myocardial infarction in patients with normal coronaries. We hereby present a 58-year-old man who presented to the emergency room with chest pain. Electrocardiogram demonstrated ST segment depression in the inferior leads with diffuse spasm of the distal right coronary artery seen on angiography, which was easily reversed by intracoronary nitroglycerine. We believe this is the first reported case of a patient with a myocardial infarction after taking oral zolmitriptan in which coronary angiogram clearly demonstrated coronary vasospasm reversal after intracoronary nitroglycerine. A detailed search of the literature for reported cases of myocardial infarction after triptan use is also provided.
曲坦类药物多年来一直被用于偏头痛的急性治疗。虽然它们的使用可能导致冠状动脉痉挛,但很少有报告表明曲坦类药物实际上会导致正常冠状动脉的患者发生心肌梗死。我们在此介绍一位 58 岁的男性患者,他因胸痛就诊于急诊科。心电图显示下导联 ST 段压低,血管造影显示右冠状动脉远端弥漫性痉挛,经冠状动脉内硝酸甘油注射后很容易逆转。我们认为这是首例报告的口服佐米曲坦后心肌梗死的病例,冠状动脉造影清楚地显示了冠状动脉内硝酸甘油注射后痉挛的逆转。还对曲坦类药物使用后心肌梗死的报告病例进行了详细的文献检索。